Annual Current Liabilities
$20.13 M
-$8.16 M-28.84%
31 December 2023
Summary:
Y-mAbs Therapeutics annual total current liabilities is currently $20.13 million, with the most recent change of -$8.16 million (-28.84%) on 31 December 2023. During the last 3 years, it has risen by +$593.00 thousand (+3.04%). YMAB annual current liabilities is now -28.84% below its all-time high of $28.28 million, reached on 31 December 2022.YMAB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$25.29 M
-$18.18 M-41.82%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly total current liabilities is currently $25.29 million, with the most recent change of -$18.18 million (-41.82%) on 30 September 2024. Over the past year, it has increased by +$3.48 million (+15.95%). YMAB quarterly current liabilities is now -41.82% below its all-time high of $43.47 million, reached on 30 June 2024.YMAB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.8% | +15.9% |
| 3 y3 years | +3.0% | -0.3% |
| 5 y5 years | +120.6% | +80.8% |
YMAB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -28.8% | +3.0% | -41.8% | +43.7% |
| 5 y | 5 years | -28.8% | +120.6% | -41.8% | +86.2% |
| alltime | all time | -28.8% | +576.6% | -41.8% | +341.6% |
Y-mAbs Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.29 M(-41.8%) |
| June 2024 | - | $43.47 M(+146.9%) |
| Mar 2024 | - | $17.61 M(-12.5%) |
| Dec 2023 | $20.13 M(-28.8%) | $20.13 M(-7.7%) |
| Sept 2023 | - | $21.81 M(-10.0%) |
| June 2023 | - | $24.23 M(-6.5%) |
| Mar 2023 | - | $25.92 M(-8.4%) |
| Dec 2022 | $28.28 M(+1.5%) | $28.28 M(-11.7%) |
| Sept 2022 | - | $32.02 M(+8.7%) |
| June 2022 | - | $29.45 M(+1.4%) |
| Mar 2022 | - | $29.04 M(+4.2%) |
| Dec 2021 | $27.88 M | $27.88 M(+9.9%) |
| Sept 2021 | - | $25.36 M(+20.8%) |
| June 2021 | - | $20.99 M(+23.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $17.00 M(-13.0%) |
| Dec 2020 | $19.54 M(+43.8%) | $19.54 M(-1.2%) |
| Sept 2020 | - | $19.78 M(+25.9%) |
| June 2020 | - | $15.71 M(+5.8%) |
| Mar 2020 | - | $14.84 M(+9.3%) |
| Dec 2019 | $13.59 M(+48.9%) | $13.59 M(-2.9%) |
| Sept 2019 | - | $13.99 M(+2.7%) |
| June 2019 | - | $13.63 M(+32.3%) |
| Mar 2019 | - | $10.30 M(+12.9%) |
| Dec 2018 | $9.12 M(+15.1%) | $9.12 M(-2.1%) |
| Sept 2018 | - | $9.32 M(+62.7%) |
| June 2018 | - | $5.73 M(-27.7%) |
| Dec 2017 | $7.92 M(+166.4%) | $7.92 M |
| Dec 2016 | $2.98 M | - |
FAQ
- What is Y-mAbs Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual current liabilities year-on-year change?
- What is Y-mAbs Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly current liabilities year-on-year change?
What is Y-mAbs Therapeutics annual total current liabilities?
The current annual current liabilities of YMAB is $20.13 M
What is the all time high annual current liabilities for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual total current liabilities is $28.28 M
What is Y-mAbs Therapeutics annual current liabilities year-on-year change?
Over the past year, YMAB annual total current liabilities has changed by -$8.16 M (-28.84%)
What is Y-mAbs Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of YMAB is $25.29 M
What is the all time high quarterly current liabilities for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly total current liabilities is $43.47 M
What is Y-mAbs Therapeutics quarterly current liabilities year-on-year change?
Over the past year, YMAB quarterly total current liabilities has changed by +$3.48 M (+15.95%)